Position in VTRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$320,873,979
+$47,888,623 QoQ
Shares Held
20,206,170
0.0% QoQ
Ownership
1.76%
of shares outstanding
% of Portfolio
5.44%
of 13F equity value
Holder Rank
#12
of 1,016 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026DEERFIELD MANAGEMENT COMPANY, L.P. holds $870,646,189 across 5 Drug Manufacturers - Specialty & Generic names. VTRS ranks #1 (36.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
This page
|
20,206,170 | $320,873,979 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
457,000 | $247,616,310 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
15,096,403 | $150,964,030 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
752,999 | $83,537,709 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,648,895 | $67,654,161 |
All Filings in VTRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $320,873,979 | 20,206,170 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $272,985,356 | 20,206,170 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $251,566,816 | 20,206,170 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $238,580,921 | 24,099,083 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $214,533,489 | 24,023,907 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $208,966,783 | 23,991,594 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $298,750,648 | 23,996,036 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $278,558,997 | 23,993,023 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $227,434,122 | 21,395,496 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $255,456,920 | 21,395,052 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $215,121,531 | 19,863,484 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $195,853,962 | 19,863,485 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $176,680,770 | 17,703,484 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $162,924,291 | 16,935,997 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $111,300,000 | 10,000,000 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $90,939,924 | 10,673,700 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $216,453,639 | 20,673,700 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $224,929,856 | 20,673,700 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $281,072,220 | 20,774,000 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $255,065,200 | 18,824,000 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $268,994,960 | 18,824,000 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $240,619,280 | 17,224,000 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $294,667,760 | 15,724,000 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||